LivaNova (LIVN) Gross Profit Growth (1y) (2015 - 2026)
LivaNova (LIVN) Gross Profit Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.74 Bn | 194.14 Bn | 7.27 Bn | 15.59% |
| 2 | Stryker | 129.74 Bn | 126.26 Bn | 4.50 Bn | 17.10% |
| 3 | Medtronic | 119.78 Bn | 110.56 Bn | 6.41 Bn | 10.88% |
| 4 | Boston Scientific | 73.98 Bn | 73.44 Bn | 3.85 Bn | 12.38% |
| 5 | Edwards Lifesciences | 52.45 Bn | 48.19 Bn | 1.35 Bn | 13.54% |
| 6 | Dexcom | 34.74 Bn | 32.79 Bn | 830.00 Mn | 20.50% |
| 7 | GE HealthCare Technologies | 34.12 Bn | 32.01 Bn | 2.18 Bn | 9.82% |
| 8 | Koninklijke Philips | 26.41 Bn | 23.09 Bn | 4.55 Bn | 4.20% |
| 9 | Steris | 23.26 Bn | 22.77 Bn | 684.20 Mn | 8.95% |
| 10 | LivaNova | 4.32 Bn | 3.80 Bn | 273.67 Mn | 14.51% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 14.51% |
| Mar 31, 2026 | 12.71% |
| Dec 31, 2025 | 11.85% |
| Sep 30, 2025 | 10.78% |
| Jun 30, 2025 | 11.22% |
| Mar 31, 2025 | 6.42% |
| Dec 31, 2024 | 22.68% |
| Sep 30, 2024 | 9.53% |
| Jun 30, 2024 | 4.72% |
| Mar 31, 2024 | 16.73% |
| Dec 31, 2023 | -4.78% |
| Sep 30, 2023 | 18.07% |
| Jun 30, 2023 | 11.31% |
| Mar 31, 2023 | 3.35% |
| Dec 31, 2022 | -8.99% |
| Sep 30, 2022 | 1.34% |
| Jun 30, 2022 | 7.01% |
| Mar 31, 2022 | 3.08% |
| Dec 31, 2021 | 20.82% |
| Sep 30, 2021 | 14.28% |